All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

HPV-Positive Laryngeal Carcinomas: Epidemiological, Virological and Progressive Features

DOI: 10.4236/oalib.1106679, PP. 1-7

Subject Areas: Epidemiology, Oncology, Otorhinolaryngology

Keywords: Larynx, Cancers, HPV, Brazzaville

Full-Text   Cite this paper   Add to My Lib

Abstract

Objective: The aim of this work was to determine the molecular prevalence of the Human Papilloma Virus (HPV) in carcinomas of the larynx and to identify its circulating genotypes. Patients and Methods: This was a descriptive, retrospective study of 20 years which included all the patients followed in otolaryngology department for laryngeal carcinoma. The virological analysis was done on the laryngeal biopsy pieces included in paraffin using the Gene Xpert technique. This technique uses real-time PCR to identify oncogenic HPV genotypes. Results: A total of 108 patients with laryngeal carcinomas were collected. Among them, 21 samples were associated with oncogenic HPV, a molecular prevalence of 19.4%. These were the HPV 18/45 (14.28%), HPV-16 (28.57%) and the group of HPVs with high oncogenic risk other than 18/45 and 16 (57.15%). All of these patients were male, mean age was 35.71 ± 3.17, and 85.7% of them were under 40 compared to patients with carcinomas not associated with HPV (p = 0.0003). Oral-genital contact was the main risk factor for contamination in all of these patients (p = 0.0002). The HPV-positive laryngeal carcinomas were all micro-invasive and the patients had better survival compared to those who had HPV-negative carcinomas (p = 0.0001). Conclusion: HPV-positive laryngeal carcinomas are most often observed in subjects under 40 years of age with good survival at 12 months. The circulating genotypes in Brazzaville are 16, 18/45 and the group of oncogenic HPVs other than 16 and 18/45.

Cite this paper

Dzon, H. B. O. , Ngouoni, G. C. , Diembi, S. , Ondzotto, G. W. , Tsierie-Tsoba, A. , Odzili, F. A. I. and Ondzotto, G. (2020). HPV-Positive Laryngeal Carcinomas: Epidemiological, Virological and Progressive Features. Open Access Library Journal, 7, e6679. doi: http://dx.doi.org/10.4236/oalib.1106679.

References

[1]  Otouana Dzon, H.B., Diembi, S., Ngouoni, G.C., Bolenga Liboko, A.F., Tsierie-Tsoba, A., Itiere Odzili, F.A. and Ondzotto, G. (2020) Cancers du larynx à Brazzaville: Difficultés de prise en charge et survie des patients. Health Science and Diseases, 21, 103-106.
[2]  Dahm, V., Haitel, A., Kaider, A., Stanisz, I., Bière, A. and Lill, C. (2018) Cancer Stage and Pack-Years, But Not p16 or HPV, Are Relevant for Survival in Hypopharyngeal and Laryngeal Squamous Cell Carcinomas. European Archives of Oto-Rhino-Laryngology, 275, 1837-1843. https://doi.org/10.1007/s00405-018-4997-1
[3]  Gomaa, M.A.M., EI Gindy, K.E., Nabi, U.G.A., Mohammed, H.M., Twab, N.A.A., Mahmoud, R. and Mohiy, K.M. (2017) Human Papillomavirus Subtype 16 and the Pathologic Characteristics of Laryngeal Cancer. OTO Open. https://doi.org/10.1177/2473974X17707925
[4]  Celebi, O.O., Sener, E., Hosal, S., Cengiz, M., Gullu, I. and Tezel, G.G. (2008) Human Papillomavirus Infection in Patients with Laryngeal Carcinoma. BMC Cancer, 18, Article No. 1005. https://doi.org/10.1186/s12885-018-4890-8
[5]  Murphy, J., Berman, D.R., Edwards, S.P., Prisciandaro, J., Eisbruch, A. and Ward, B.B. (2016) Squamous Cell Carcinoma of the Tongue during Pregnancy: A Case Reort and Review of the Literature. Journal of Oral and Maxillofacial Surgery, 74, 2557-2566. https://doi.org/10.1007/s00405-018-4997-1
[6]  Njimah, N.A., Ngnembi, A.R., Essama, L., Fewou, A., Kouotou, E.A., Minka, E. and Njock, L.R. (2018) Aspects Anatomopathologiques des Cancers ORL et Cervico-faciaux à l’Hôpital Général de Douala. Health Science and Diseases, 19, 39-44.
[7]  Amana, B., Foma, W., Pegbessou, E., Adam, S., Amana, E., Amégbor, K., et al. (2016) Cancers primitifs Oto-Rhino-Laryngologiques et Cervico-Maxillo-Faciaux: Aspects épidémiologiques et histopathologiques. The Pan African Medical Journal, 25, 47-53. https://doi.org/10.11604/pamj.2016.25.47.9953
[8]  Dayyani, F., Etzel, C.J., Liu, M., Ho, C.-H., Lippman, S.M. and Tsao, A.S. (2016) Meta-Analysis of the Impact of Human Papillomavirus (HPV) on Cancer Risk, Overall Survival in Head, Neck Squamous Cell Carcinomas (HNSCC). Head & Neck Oncology, 2, Article No. 15. https://doi.org/10.1186/1758-3284-2-15
[9]  Chaturvedi, A.K., Engels, E.A., Anderson, W.F. and Gillison, M.L. (2018) Incidence Trends for Human Papillomavirus-Related and -Unrelated Oral Squamous Cell Carcinomas in the United States. Journal of Clinical Oncology, 26, 612-619. https://doi.org/10.1200/JCO.2007.14.1713
[10]  Si-Mohamed, A., Badoual, C., Hans, S., Péréa, H., Tartourd, E. and Brasnu, D. (2017) An Unusual Human Papillomavirus Type 82 Detection in Laryngeal Squamous Cell Carcinoma: Case Report and Review of Literature. Journal of Clinical Virology, 54, 190-193. https://doi.org/10.1016/j.jcv.2012.02.024
[11]  Kreimer, A.R., Clifford, G.M., Boyle, P. and Franceschi, S. (2018) Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review. Cancer Epidemiology, Biomarkers & Prevention, 14, 467-475. https://doi.org/10.1158/1055-9965.EPI-04-0551
[12]  Gillison, M.L., Broutian, T., Pickard, R.K., et al. (2017) Prevalence of Oral HPV Infection in the United States, 2009-2010. JAMA, 307, 693-703. https://doi.org/10.1001/jama.2012.101
[13]  D’Souza, G., Kreimer, A.R., Viscidi, R., et al. (2017) Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. The New England Journal of Medicine, 356, 1944-1956. https://doi.org/10.1056/NEJMoa065497
[14]  Chernock, R.D., Lewis Jr., J.S., Zhang, Q. and El-Mofty, S.K. (2016) Human Papillomavirus-Positive Basaloid Squamous Cell Carcinomas of the Upper Aerodigestive Tract: A Distinct Clinicopathologic and Molecular Subtype of Basaloid Squamous Cell Carcinoma. Human Pathology, 41, 1016-1023. https://doi.org/10.1016/j.humpath.2009.11.015
[15]  Shoushtari, A.N., Rahimi, N.P., Schlesinger, D.J. and Read, P.W. (2016) Survey on Human Papillomavirus/P16 Screening Use in Oropharyngeal Carcinoma Patients in the United States. Cancer, 116, 514-519. https://doi.org/10.1002/cncr.24752
[16]  Worden, F.P., Kumar, B., Lee, J.S., et al. (2018) Chemoselection as a Strategy for Organ Preservation in Advanced Oropharynx Cancer: Response and Survival Positively Associated with HPV16 Copy Number. Journal of Clinical Oncology, 26, 3138-3146. https://doi.org/10.1200/JCO.2007.12.7597
[17]  Drop, B., Strycharz-Dudziak, M., Kliszczewska, E. and Polz-Dacewicz, M. (2017) Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in Laryngeal, Oropharyngeal and Oral Cavity Cancer. International Journal of Molecular Sciences, 18, 2752. https://doi.org/10.3390/ijms18122752
[18]  Niu, J.T., Liu, S.G., Huang, Y.W. and Li, C. (2018) Effet de miR-497 sur l’invasion du carcinome épidermoïde du larynx par le biais de la modulation du Plexin A4. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 53, 124-130.

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

微信:OALib Journal